TRIMETHOPRIM Drug Patent Profile
✉ Email this page to a colleague
When do Trimethoprim patents expire, and when can generic versions of Trimethoprim launch?
Trimethoprim is a drug marketed by Dr Reddys Labs Sa, Novel Labs Inc, Novitium Pharma, Sun Pharm Industries, Teva, Watson Labs, Bausch And Lomb, Epic Pharma Llc, and Sandoz. and is included in ten NDAs.
The generic ingredient in TRIMETHOPRIM is polymyxin b sulfate; trimethoprim sulfate. There are twelve drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the polymyxin b sulfate; trimethoprim sulfate profile page.
Summary for TRIMETHOPRIM
US Patents: | 0 |
Applicants: | 9 |
NDAs: | 10 |
Finished Product Suppliers / Packagers: | 6 |
Raw Ingredient (Bulk) Api Vendors: | 172 |
Clinical Trials: | 183 |
Patent Applications: | 4,086 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for TRIMETHOPRIM |
What excipients (inactive ingredients) are in TRIMETHOPRIM? | TRIMETHOPRIM excipients list |
DailyMed Link: | TRIMETHOPRIM at DailyMed |
Recent Clinical Trials for TRIMETHOPRIM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Johns Hopkins University | Early Phase 1 |
The Cleveland Clinic | Phase 4 |
Assistance Publique - Hôpitaux de Paris | Phase 4 |